IL1B and type 2 diabetes mellitus: Studies have proposed that the underlying mechanisms of quercetin action against T2DM may be by downregulating the RNA and protein levels of MAPK, TNF-α, IL-6, and IL-1B in rat pancreatic tissue48,49, which is consistent with the PPI network results in this study.